{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T02:14:52Z","timestamp":1790648092650,"version":"4.1.0"},"reference-count":57,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T00:00:00Z","timestamp":1638921600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["75N93019C00074"],"award-info":[{"award-number":["75N93019C00074"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013017","name":"Vanderbilt University Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013017","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","award":["3UL1TR002243-04S4"],"award-info":[{"award-number":["3UL1TR002243-04S4"]}],"id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000848","name":"University of Edinburgh","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006369","name":"George Mason University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006369","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000185","name":"Defense Advanced Research Projects Agency","doi-asserted-by":"publisher","award":["HR0011-18-2-0001"],"award-info":[{"award-number":["HR0011-18-2-0001"]}],"id":[{"id":"10.13039\/100000185","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006537","name":"Vanderbilt University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004322","name":"Agilent Technologies","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011912","name":"Washington University School of Medicine in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011912","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["iScience"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.isci.2021.103602","type":"journal-article","created":{"date-parts":[[2021,12,8]],"date-time":"2021-12-08T12:12:58Z","timestamp":1638965578000},"page":"103602","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Standardized two-step testing of antibody activity in COVID-19 convalescent plasma"],"prefix":"10.1016","volume":"25","author":[{"given":"Pavlo","family":"Gilchuk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9240-0164","authenticated-orcid":false,"given":"Isaac","family":"Thomsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3725-9660","authenticated-orcid":false,"given":"Sandra","family":"Yoder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Brady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D.","family":"Chappell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R.","family":"Denison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E.","family":"Sutton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita E.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"VanBlargan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2571-1290","authenticated-orcid":false,"given":"Naveenchandra","family":"Suryadevara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6712-5076","authenticated-orcid":false,"given":"Seth J.","family":"Zost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Schmitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill M.","family":"Pulley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael S.","family":"Diamond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jillian P.","family":"Rhoads","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4721-3068","authenticated-orcid":false,"given":"Gordon R.","family":"Bernard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wesley H.","family":"Self","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7136-5408","authenticated-orcid":false,"given":"Todd W.","family":"Rice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3967-4873","authenticated-orcid":false,"given":"Allison P.","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr.","given":"James E.","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5230-1532","authenticated-orcid":false,"given":"Robert H.","family":"Carnahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.isci.2021.103602_bib1","doi-asserted-by":"crossref","first-page":"e02107","DOI":"10.1128\/JCM.02107-20","article-title":"Neutralizing antibodies correlate with protection from SARS-CoV-2 in humans during a fishery vessel outbreak with a high attack rate","volume":"58","author":"Addetia","year":"2020","journal-title":"J.\u00a0Clin. Microbiol."},{"key":"10.1016\/j.isci.2021.103602_bib2","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa2028436","article-title":"Safety and immunogenicity of SARS-CoV-2 mRNA-1273 vaccine in older adults","volume":"383","author":"Anderson","year":"2020","journal-title":"N.Engl. J. Med."},{"key":"10.1016\/j.isci.2021.103602_bib3","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1056\/NEJMoa2035389","article-title":"Efficacy and safety of the mRNA-1273 SARS-CoV-2 vaccine","volume":"384","author":"Baden","year":"2021","journal-title":"N.Engl. J. Med."},{"key":"10.1016\/j.isci.2021.103602_bib4","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1126\/science.abe2402","article-title":"REGN-COV2 antibodies prevent and treat SARS-CoV-2 infection in rhesus macaques and hamsters","volume":"370","author":"Baum","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2021.103602_bib5","doi-asserted-by":"crossref","first-page":"102052","DOI":"10.1016\/j.isci.2021.102052","article-title":"A high-throughput liquid bead array assay confirms strong correlation between SARS-CoV-2 antibody level and COVID-19 severity","volume":"24","author":"Bennett","year":"2021","journal-title":"iScience"},{"key":"10.1016\/j.isci.2021.103602_bib6","doi-asserted-by":"crossref","first-page":"e144930","DOI":"10.1172\/JCI144930","article-title":"Clinical, laboratory, and temporal predictors of neutralizing antibodies against SARS-CoV-2 among COVID-19 convalescent plasma donor candidates","volume":"131","author":"Boonyaratanakornkit","year":"2021","journal-title":"J.\u00a0Clin. Invest."},{"key":"10.1016\/j.isci.2021.103602_bib7","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1093\/infdis\/jiaa505","article-title":"Severe acute respiratory syndrome coronavirus 2 neutralizing antibody titers in convalescent plasma and recipients in New Mexico: an open treatment study in patients with coronavirus disease 2019","volume":"222","author":"Bradfute","year":"2020","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2021.103602_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.virol.2020.05.015","article-title":"Growth, detection, quantification, and inactivation of SARS-CoV-2","volume":"548","author":"Case","year":"2020","journal-title":"Virology"},{"key":"10.1016\/j.isci.2021.103602_bib9","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/j.chom.2020.06.021","article-title":"Neutralizing antibody and soluble ACE2 Inhibition of a replication-competent VSV-SARS-CoV-2 and a clinical isolate of SARS-CoV-2","volume":"28","author":"Case","year":"2020","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2021.103602_bib10","article-title":"Convergent antibody responses to the SARS-CoV-2 spike protein in convalescent and vaccinated individuals","author":"Chen","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2021.103602_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-021-03720-y","article-title":"In\u00a0vivo monoclonal antibody efficacy against SARS-CoV-2 variant strains","author":"Chen","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.103602_bib12","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/s41591-021-01294-w","article-title":"Resistance of SARS-CoV-2 variants to neutralization by monoclonal and serum-derived polyclonal antibodies","volume":"27","author":"Chen","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2021.103602_bib13","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1126\/science.abc6952","article-title":"A neutralizing human antibody binds to the N-terminal domain of the Spike protein of SARS-CoV-2","volume":"369","author":"Chi","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2021.103602_bib14","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S2666-5247(21)00025-2","article-title":"Dynamics of SARS-CoV-2 neutralising antibody responses and duration of immunity: a longitudinal study","volume":"2","author":"Chia","year":"2021","journal-title":"Lancet Microbe"},{"key":"10.1016\/j.isci.2021.103602_bib15","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1056\/NEJMc2031364","article-title":"Persistence and evolution of SARS-CoV-2 in an immunocompromised host","volume":"383","author":"Choi","year":"2020","journal-title":"N.Engl. J. Med."},{"key":"10.1016\/j.isci.2021.103602_bib16","article-title":"Immune correlates of protection by mRNA-1273 immunization against SARS-CoV-2 infection in nonhuman primates","author":"Corbett","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2021.103602_bib22","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1038\/s41551-020-0594-x","article-title":"Integrated pipeline for the accelerated discovery of antiviral antibody therapeutics","volume":"4","author":"Gilchuk","year":"2020","journal-title":"Nat. Biomed. Eng."},{"key":"10.1016\/j.isci.2021.103602_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.immuni.2020.01.001","article-title":"Analysis of a therapeutic antibody cocktail reveals determinants for cooperative and broad ebolavirus neutralization","volume":"52","author":"Gilchuk","year":"2020","journal-title":"Immunity"},{"key":"10.1016\/j.isci.2021.103602_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/trf.16101","article-title":"SARS-CoV-2 neutralization and serology testing of COVID-19 convalescent plasma from donors with nonsevere disease","volume":"61","author":"Gniadek","year":"2021","journal-title":"Transfusion"},{"key":"10.1016\/j.isci.2021.103602_bib25","doi-asserted-by":"crossref","first-page":"eabc3103","DOI":"10.1126\/scitranslmed.abc3103","article-title":"A comparison of four serological assays for detecting anti-SARS-CoV-2 antibodies in human serum samples from different populations","volume":"12","author":"Grzelak","year":"2020","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2021.103602_bib26","doi-asserted-by":"crossref","first-page":"ofaa555","DOI":"10.1093\/ofid\/ofaa555","article-title":"SARS-CoV-2 serologic assay needs for the next phase of the US COVID-19 pandemic response","volume":"8","author":"Gundlapalli","year":"2021","journal-title":"Open Forum Infect. Dis."},{"key":"10.1016\/j.isci.2021.103602_bib27","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa2022483","article-title":"An mRNA Vaccine against SARS-CoV-2 - preliminary report","volume":"383","author":"Jackson","year":"2020","journal-title":"N.Engl. J. Med."},{"key":"10.1016\/j.isci.2021.103602_bib28","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1001\/jama.2021.2747","article-title":"Association of convalescent plasma treatment with clinical outcomes in patients with COVID-19: a systematic review and meta-analysis","volume":"325","author":"Janiaud","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.isci.2021.103602_bib29","doi-asserted-by":"crossref","first-page":"eabf1906","DOI":"10.1126\/scitranslmed.abf1906","article-title":"The neutralizing antibody, LY-CoV555, protects against SARS-CoV-2 infection in nonhuman primates","volume":"13","author":"Jones","year":"2021","journal-title":"Sci. Transl. Med."},{"key":"10.1016\/j.isci.2021.103602_bib30","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1056\/NEJMoa2031893","article-title":"Convalescent plasma antibody levels and the risk of death from Covid-19","volume":"384","author":"Joyner","year":"2021","journal-title":"N.Engl. J. Med."},{"key":"10.1016\/j.isci.2021.103602_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/s41586-021-03291-y","article-title":"SARS-CoV-2 evolution during treatment of chronic infection","volume":"592","author":"Kemp","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.103602_bib32","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41577-020-00471-1","article-title":"Measuring immunity to SARS-CoV-2 infection: comparing assays and animal models","volume":"20","author":"Khoury","year":"2020","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2021.103602_bib33","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1038\/s41591-021-01377-8","article-title":"Neutralizing antibody levels are highly predictive of immune protection from symptomatic SARS-CoV-2 infection","volume":"27","author":"Khoury","year":"2021","journal-title":"Nat. Med."},{"key":"10.1016\/j.isci.2021.103602_bib34","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1016\/S0140-6736(21)00782-0","article-title":"Correlates of protection from SARS-CoV-2 infection","volume":"397","author":"Krammer","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.isci.2021.103602_bib35","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1126\/science.abc1227","article-title":"Serology assays to manage COVID-19","volume":"368","author":"Krammer","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2021.103602_bib37","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1038\/s41423-020-00588-2","article-title":"A longitudinal study of SARS-CoV-2-infected patients reveals a high correlation between neutralizing antibodies and COVID-19 severity","volume":"18","author":"Legros","year":"2021","journal-title":"Cell. Mol. Immunol."},{"key":"10.1016\/j.isci.2021.103602_bib38","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1056\/NEJMoa2033700","article-title":"Early high-titer plasma therapy to prevent severe Covid-19 in older adults","volume":"384","author":"Libster","year":"2021","journal-title":"N.Engl. J. Med."},{"key":"10.1016\/j.isci.2021.103602_bib39","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1038\/s41586-020-2571-7","article-title":"Potent neutralizing antibodies against multiple epitopes on SARS-CoV-2 spike","volume":"584","author":"Liu","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.103602_bib40","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.chom.2021.01.014","article-title":"Identification of SARS-CoV-2 spike mutations that attenuate monoclonal and serum antibody neutralization","volume":"29","author":"Liu","year":"2021","journal-title":"Cell Host Microbe"},{"key":"10.1016\/j.isci.2021.103602_bib41","article-title":"Harmonization of Zika neutralization assays by using the WHO International Standard for anti-Zika virus antibody","volume":"4","author":"Mattiuzz","year":"2019","journal-title":"NPJ Vaccin."},{"key":"10.1016\/j.isci.2021.103602_bib42","series-title":"Establishment of the WHO International Standard and Reference Panel for Anti-SARS-CoV-2 Antibody","author":"Mattiuzzo","year":"2020"},{"key":"10.1016\/j.isci.2021.103602_bib43","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1016\/j.cell.2021.03.028","article-title":"N-terminal domain antigenic mapping reveals a site of vulnerability for SARS-CoV-2","volume":"184","author":"McCallum","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2021.103602_bib44","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1126\/science.abf6950","article-title":"Recurrent deletions in the SARS-CoV-2 spike glycoprotein drive antibody escape","volume":"371","author":"McCarthy","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2021.103602_bib45","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-03041-6","article-title":"Correlates of protection against SARS-CoV-2 in rhesus macaques","volume":"590","author":"McMahan","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.103602_bib46","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1093\/infdis\/jiaa659","article-title":"Longitudinal serological analysis and neutralizing antibody levels in coronavirus disease 2019 convalescent patients","volume":"223","author":"Muecksch","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2021.103602_bib47","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/s41586-020-2349-y","article-title":"Cross-neutralization of SARS-CoV-2 by a human monoclonal SARS-CoV antibody","volume":"583","author":"Pinto","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.103602_bib48","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1056\/NEJMoa2034577","article-title":"Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine","volume":"383","author":"Polack","year":"2020","journal-title":"N.Engl. J. Med."},{"key":"10.1016\/j.isci.2021.103602_bib49","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/infdis\/jiaa797","article-title":"SARS-CoV-2 serologic assays in control and unknown populations demonstrate the necessity of virus neutralization testing","volume":"223","author":"Rathe","year":"2021","journal-title":"J.\u00a0Infect. Dis."},{"key":"10.1016\/j.isci.2021.103602_bib50","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41586-020-2456-9","article-title":"Convergent antibody responses to SARS-CoV-2 in convalescent individuals","volume":"584","author":"Robbiani","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.103602_bib51","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1126\/science.abc7520","article-title":"Isolation of potent SARS-CoV-2 neutralizing antibodies and protection from disease in a small animal model","volume":"369","author":"Rogers","year":"2020","journal-title":"Science"},{"key":"10.1016\/j.isci.2021.103602_bib52","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.ajpath.2020.10.008","article-title":"Significantly decreased mortality in a large cohort of coronavirus disease 2019 (COVID-19) patients transfused early with convalescent plasma containing high-titer anti-severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein IgG","volume":"191","author":"Salazar","year":"2021","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.isci.2021.103602_bib53","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1186\/s13063-021-05171-2","article-title":"Passive Immunity Trial for Our Nation (PassITON): study protocol for a randomized placebo-control clinical trial evaluating COVID-19 convalescent plasma in hospitalized adults","volume":"22","author":"Self","year":"2021","journal-title":"Trials"},{"key":"10.1016\/j.isci.2021.103602_bib54","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1016\/j.cell.2021.03.029","article-title":"Neutralizing and protective human monoclonal antibodies recognizing the N-terminal domain of the SARS-CoV-2 spike protein","volume":"184","author":"Suryadevara","year":"2021","journal-title":"Cell"},{"key":"10.1016\/j.isci.2021.103602_bib55","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1093\/clinchem\/hvaa211","article-title":"Association between SARS-CoV-2 neutralizing antibodies and commercial serological assays","volume":"66","author":"Tang","year":"2020","journal-title":"Clin. Chem."},{"key":"10.1016\/j.isci.2021.103602_bib56","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/s41577-021-00542-x","article-title":"Neutralizing monoclonal antibodies for treatment of COVID-19","volume":"21","author":"Taylor","year":"2021","journal-title":"Nat. Rev. Immunol."},{"key":"10.1016\/j.isci.2021.103602_bib57","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1007\/s10096-020-04128-8","article-title":"Inference of SARS-CoV-2 spike-binding neutralizing antibody titers in sera from hospitalized COVID-19 patients by using commercial enzyme and chemiluminescent immunoassays","volume":"40","author":"Valdivia","year":"2021","journal-title":"Eur. J. Clin. Microbiol. Infect. Dis."},{"key":"10.1016\/j.isci.2021.103602_bib58","article-title":"A potently neutralizing anti-SARS-CoV-2 antibody inhibits variants of concern by binding a highly conserved epitope","author":"VanBlargan","year":"2021","journal-title":"bioRxiv"},{"key":"10.1016\/j.isci.2021.103602_bib59","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1126\/science.abg5268","article-title":"Prevalent, protective, and convergent IgG recognition of SARS-CoV-2 non-RBD spike epitopes","volume":"372","author":"Voss","year":"2021","journal-title":"Science"},{"key":"10.1016\/j.isci.2021.103602_bib60","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1038\/s41586-021-03398-2","article-title":"Antibody resistance of SARS-CoV-2 variants B.1.351 and B.1.1.7","volume":"593","author":"Wang","year":"2021","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.103602_bib61","doi-asserted-by":"crossref","first-page":"eabc3582","DOI":"10.1126\/sciimmunol.abc3582","article-title":"TMPRSS2 and TMPRSS4 promote SARS-CoV-2 infection of human small intestinal enterocytes","volume":"5","author":"Zang","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.isci.2021.103602_bib62","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/s41586-020-2548-6","article-title":"Potently neutralizing and protective human antibodies against SARS-CoV-2","volume":"584","author":"Zost","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.isci.2021.103602_bib63","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1038\/s41591-020-0998-x","article-title":"Rapid isolation and profiling of a diverse panel of human monoclonal antibodies targeting the SARS-CoV-2 spike protein","volume":"26","author":"Zost","year":"2020","journal-title":"Nat. Med."}],"container-title":["iScience"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004221015728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589004221015728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T19:29:26Z","timestamp":1762630166000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589004221015728"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":57,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2589004221015728"],"URL":"https:\/\/doi.org\/10.1016\/j.isci.2021.103602","relation":{},"ISSN":["2589-0042"],"issn-type":[{"value":"2589-0042","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Standardized two-step testing of antibody activity in COVID-19 convalescent plasma","name":"articletitle","label":"Article Title"},{"value":"iScience","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.isci.2021.103602","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Authors.","name":"copyright","label":"Copyright"}],"article-number":"103602"}}